Moderate Risk of Hepatitis B Virus Reactivation in HBsAg-/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis.
Sci Rep
; 10(1): 2456, 2020 02 12.
Article
in En
| MEDLINE
| ID: mdl-32051458
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Hepatitis B virus
/
Antirheumatic Agents
/
Rituximab
/
Hepatitis B
/
Antibodies, Viral
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
Sci Rep
Year:
2020
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Reino Unido